Finilac vet.
Active substance
ATC code
Species
Dogs, cats
Indications
Treatment of false pregnancy in bitches
Suppression of lactation in bitches and queens
Dose to be administered and administration route
The product should be administered orally either directly into the mouth or by mixing with food.
The dosage is 0.1 ml/kg bodyweight (equivalent to 5 microgram/kg bodyweight of cabergoline) once daily for 4-6 consecutive days, depending on the severity of the clinical condition.
If the signs fail to resolve after a single course of treatment, or if they recur after the end of treatment, then the course of treatment may be repeated.
The weight of treated animal should be accurately determined before administration.
Adverse reactions
In very rare cases a transient hypotension may occur Possible adverse effects are:
- sleepiness
- anorexia
- vomiting
These adverse effects are usually of a moderate and transient nature.
Vomiting usually only occurs after the first administration. In this case treatment should not be stopped, since the vomiting is unlikely to reoccur after the following administrations.
In very rare cases allergic reactions may occur, such as oedema, urticaria, dermatitis and pruritus.
In very rare cases neurological symptoms may occur, such as sleepiness, muscle tremor, ataxia, hyperactivity and convulsions.
The frequency of adverse reactions is defined using the following convention:
- very common (more than 1 in 10 animals treated displaying adverse reaction(s))
- common (more than 1 but less than 10 animals in 100 animals treated)
- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
- rare (more than 1 but less than 10 animals in 10,000 animals treated)
- very rare (less than 1 animal in 10,000 animals treated, including isolated reports).
| PRICE | Only for registered vets. Create a free profile to access all features.. Login |
|---|---|
| Art. Nr. | 41821/5023 |
| EAN | 8718469446629 |
Similar products
Showing 1 of 1 results
